Ray Dalio’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.4M | Sell |
618,428
-418,924
| -40% | -$32.3M | 0.2% | 81 |
|
|
2025
Q4 | $82.3M | Sell |
1,037,352
-155,792
| -13% | -$12.3M | 0.3% | 53 |
|
|
2025
Q3 | $90M | Buy |
1,193,144
+356,556
| +43% | +$24.4M | 0.35% | 52 |
|
|
2025
Q2 | $57.7M | Buy |
836,588
+526,739
| +170% | +$34.5M | 0.23% | 80 |
|
|
2025
Q1 | $21M | Buy |
309,849
+148,345
| +92% | +$8.88M | 0.1% | 176 |
|
|
2024
Q4 | $7.25M | Sell |
161,504
-592,648
| -79% | -$33.2M | 0.03% | 302 |
|
|
2024
Q3 | $47.4M | Sell |
754,152
-489,414
| -39% | -$28.6M | 0.27% | 69 |
|
|
2024
Q2 | $73.4M | Sell |
1,243,566
-1,211,051
| -49% | -$75.8M | 0.38% | 47 |
|
|
2024
Q1 | $196M | Sell |
2,454,617
-599,787
| -20% | -$45.8M | 0.99% | 21 |
|
|
2023
Q4 | $241M | Buy |
3,054,404
+164,323
| +6% | +$11.7M | 1.35% | 14 |
|
|
2023
Q3 | $202M | Buy |
2,890,081
+203,663
| +8% | +$14.4M | 1.22% | 15 |
|
|
2023
Q2 | $186M | Buy |
2,686,418
+212,648
| +9% | +$15.1M | 1.15% | 17 |
|
|
2023
Q1 | $184M | Sell |
2,473,770
-266,179
| -10% | -$22.3M | 1.12% | 17 |
|
|
2022
Q4 | $255M | Sell |
2,739,949
-339,755
| -11% | -$32.8M | 1.39% | 14 |
|
|
2022
Q3 | $294M | Sell |
3,079,704
-66,532
| -2% | -$6.59M | 1.49% | 14 |
|
|
2022
Q2 | $292M | Buy |
3,146,236
+1,935,319
| +160% | +$189M | 1.24% | 14 |
|
|
2022
Q1 | $123M | Buy |
1,210,917
+428,611
| +55% | +$45M | 0.49% | 31 |
|
|
2021
Q4 | $80.7M | Sell |
782,306
-275,969
| -26% | -$25.5M | 0.47% | 40 |
|
|
2021
Q3 | $89.8M | Sell |
1,058,275
-136,407
| -11% | -$11.4M | 0.49% | 38 |
|
|
2021
Q2 | $99.7M | Buy |
1,194,682
+405,075
| +51% | +$33.2M | 0.64% | 27 |
|
|
2021
Q1 | $59.4M | Sell |
789,607
-28,172
| -3% | -$2.05M | 0.52% | 34 |
|
|
2020
Q4 | $55.9M | Buy |
817,779
+483,975
| +145% | +$31.5M | 0.48% | 34 |
|
|
2020
Q3 | $19.5M | Buy |
333,804
+320,039
| +2,325% | +$19.9M | 0.23% | 49 |
|
|
2020
Q2 | $894K | Sell |
13,765
-17,764
| -56% | -$1.12M | 0.02% | 196 |
|
|
2020
Q1 | $1.87M | Buy |
+31,529
| New | +$2.1M | 0.04% | 135 |
|
|
2019
Q4 | – | Sell |
-210,030
| Closed | -$13.2M | – | 504 |
|
|
2019
Q3 | $13.2M | Sell |
210,030
-236,951
| -53% | -$14M | 0.12% | 82 |
|
|
2019
Q2 | $24.4M | Sell |
446,981
-189,199
| -30% | -$10.2M | 0.19% | 46 |
|
|
2019
Q1 | $34.3M | Buy |
636,180
+38,770
| +6% | +$2.39M | 0.21% | 27 |
|
|
2018
Q4 | $39.1M | Buy |
597,410
+505,194
| +548% | +$37.7M | 0.36% | 32 |
|
|
2018
Q3 | $7.26M | Sell |
92,216
-606,551
| -87% | -$43.4M | 0.08% | 95 |
|
|
2018
Q2 | $45M | Buy |
698,767
+28,583
| +4% | +$1.88M | 0.45% | 18 |
|
|
2018
Q1 | $41.7M | Buy |
670,184
+249,489
| +59% | +$17.9M | 0.4% | 18 |
|
|
2017
Q4 | $30.5M | Buy |
+420,695
| New | +$30.6M | 0.25% | 20 |
|
|
2017
Q2 | – | Sell |
-161,883
| Closed | -$12.7M | – | 356 |
|
|
2017
Q1 | $12.7M | Buy |
161,883
+52,870
| +48% | +$4.22M | 0.14% | 39 |
|
|
2016
Q4 | $8.6M | Buy |
+109,013
| New | +$8.82M | 0.08% | 92 |
|
|
2016
Q3 | – | Sell |
-149,700
| Closed | -$14.3M | – | 327 |
|
|
2016
Q2 | $14.3M | Buy |
+149,700
| New | +$14.9M | 0.18% | 40 |
|
|
2016
Q1 | – | Sell |
-83,137
| Closed | -$8.13M | – | 270 |
|
|
2015
Q4 | $8.13M | Buy |
+83,137
| New | +$8.14M | 0.11% | 86 |
|
|
2015
Q1 | – | Sell |
-55,411
| Closed | -$5.34M | – | 350 |
|
|
2014
Q4 | $5.34M | Buy |
+55,411
| New | +$4.88M | 0.04% | 100 |
|
|
2013
Q4 | – | Sell |
-175,050
| Closed | -$9.93M | – | 310 |
|
|
2013
Q3 | $9.93M | Buy |
+175,050
| New | +$10.4M | 0.08% | 41 |
|
Other funds holding CVS
VCM
VPM
Ray Dalio's CVS Position: Q1 2026 in Review
Ray Dalio reduced its CVS Health (CVS) stake by 40% in Q1 2026, selling an estimated $32.3M and leaving 618,428 shares worth $44.4M. The position accounts for 0.2% of the portfolio, ranked #81.
Ray Dalio first reported a position in CVS in Q3 2013 and has held it in 39 quarters since. The position peaked at $294M in Q3 2022. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Ray Dalio held 618,428 shares of CVS Health worth $44.4M as of Q1 2026.
- Ray Dalio sold 418,924 CVS Health shares in Q1 2026, an estimated $32.3M.
- CVS Health made up 0.2% of Ray Dalio's portfolio in Q1 2026, its #81 holding.
- Ray Dalio first reported a position in CVS Health in Q3 2013 and has held it in 39 quarters since.
- Ray Dalio's CVS Health position peaked at $294M in Q3 2022.
- 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.